Taking out prior high, would be a nice short term trade. Buyers will be coming in from all over once alerts go off that a new high was made and that pattern is revealed on the charts.
On the 5 and 10 minute chart today you can see more clearly how key the 4.61 breakout point was resistance as I expected. A close above would certainly be very bullish, in any case it broke it today , so it will most likely be going higher very short term. Volume pullback is very weak, also very bullish. So Stem_Cur, how did you also identify that level yesterday?
Stem_cur , curious how you came up with that price point of 4.61. It happens to be a trendline channel on my chart for today, but its something I developed. Wondering if you used another methodology. Thanks in advance.
Wow new high on the DOW, never saw that coming, lol. Amazing how the chart says one thing while news sources try to scare everyone with threats of Russia and Crimea etc. Also, dont see the set up of CUR making a move to the pivot level of $6.10, now that would be weird. I think buying safely once CUR breaks above $5 will be one of the easier ~ 20% returns of the year, IMHO.
Let him sit it out at $4.19. He will start taking a position when CUR is above $6.10, the next target of this move up once we take out the old high. $5 wont even be a speed bump, IMHO.
Two of the top 5 selling drugs in 2013 were the following two antidepressants.
1 Abilify $6,460,215,394
5 Cymbalta $5,219,860,418
NSI189 could be mega huge if it gets a piece of this pie. What I'm wondering is if the drug companies will let it get to the market as is, if it can be a potential cure.
Another guy wrote on the memory effect of NSI -189 , very interesting. A number of anti-depressants have a problem in how they affect memory and require constant dosing, this may not be the case NS-189. It may be prescribed for a two month period like antibiotics to treat the ailment.
" I also stated a while back in this thread that NSI-189 did not have any significant effect on my memory. Having recently gone through my own notes during my 2 trials of NSI-189 (not posted here) that is definitely not true. I actually did get a rather large memory improvement right after the end of the first trial, around the same time as the motivational surge came charging in. I just didn't notice it as much because the motivation boost was so big. So NSI-189 did improve my memory quite a bit..."
Very interesting stuff, thanks for the tip. Some of the comments by people using this product are very, very positive as a treatment fro depression. One person, the moderator, wrote the following as part of the etst group:
"The magic really started happening for me when I stopped taking this stuff. Took it for 30 days total and towards the end the sweet spot seemed to be 30mg in the morning which had the least side effects for me. An afternoon dose seemed to throw me off a bit.
Anyway, I was worried about stopping it because I felt quite a bit of improvement and thought it was an acute effect of the drug. But since stopping I feel like all my depression symptoms are gone. I'm fairly certain it was a direct effect of this substance. A spontaneous resolution of depression symptoms is definitely not typical for me at all in the middle of February. Last year at this time I was spending every day in my house, isolating and working on art projects..."
Wondering if this is all hippocampus related. If so, it would explain the number of people who noticed memory improvement while trying to find the correct dose level. All in all worth the read for another potential blockuster.
Based on today's action, looking for a move to $6 range. Now just need some patience to start execute buying on a breakout, as I'm not a bottom buyer. Looking very good, good luck longs, patience!
Nice move as expected. Today's close important to see how soon we get over $5. DOW looking interesting, we may be making new highs in the next 2 weeks, hopefully. This is regardless to how world events are trying to scare the public.
No pump and dump, there was no pump. Barely any action in twitter.
BCLI is only a company selling for under $60 million with a revolutionary treatment for Parkinson's and ALS (together a multi-billion dollar market) currently testing at the Mayo. It was only a matter of time that someone with deeper pockets was going to take some positions for this rocket.
I remember years ago trading Jazz at $6 for a nice swing trade, LOL. Traders come and go and miss the boat all the time.
Yes the website is very extensive, thanks for the suggestion. Basically, looks to cover any brain nerve deficiency from Alzheimer's to Brain Trauma. What I was hoping to hear was post the ALS results, what were people in the know on this board (each board has them) most excited about for relatively quick and dramatic revenue realization.
I am a holder of both BCLI and CUR, a little bit more in the know on BCLI. Even though I'm very excited about BCLI ALS treatment (search Stem Cell ALS Rabbi Youtube, you can actually see a post treatment coverage by a patient. It would be interesting to see the same for April. The rabbi in the video was unable to teach class or walk by himself anymore prior to the treatment). What can be much bigger for BCLI is their Parkinson treatment. Interesting, that on the CUR site ALS is on the top but Parkinson is much lower, I would have thought that they also would be seeing dramatic results with their treatment on Parkinson patients. Perhaps none were in their study yet, dont know. Both companies look very interesting and finally provide hope for terrifying illnesses.
Thanks for the helpful posters who are taking all inquisitive questions, even dumb ones, seriously. Good luck longs.
Trying to understand the scope of the market for CUR. Does anyone know if management believes their treatment can be expanded to treat other illnesses. BCLI's people have pointed out that the their ALS treatment has had more remarkable results with Parkinson symptoms. My guess is that they are trying to expedite the process by getting emergency approval for ALS, then they can also quickly get the Parkinson market. Anyone know if CUR is doing the same. Do they just need the door open and then they hope to go after other markets, if so, for what ailments?.
Basically, trying to understand the potential market for CUR, the ALS market is relatively small with 2 potential treatments over the horizon. What is the broader target for their treatments.
I think once we break 3.85 and head to 4, people will be looking for some education on CUR. Thanks
Good news from Mayo can pop the price over .75 easily in one day, enjoy the days at these levels.
I like how CUR has allowed one of their test subjects to release some status info in her blog. It has helped the share price climb. I Wouldn't be surprised if the same happens here, I'm sure there will be leaks.
A strength of CUR over BCLI is the treatment lasts longer. BCLI saw some degeneration at the 6 month mark, which called for a second procedure. CUR has a stable state lasting over 2 years +. BCLI seems to have stronger reversal of symptoms then CUR's treatment.
Some sort of partnership may be of benefit to both companies.
Granted a number of people on this board are focusing on the $$$. But any thoughts pro or con on such a synergy to create a viable treatment? They both have their strengths ( I am truly not an expert, just seeking some DD), CUR possibly more so. But I have not heard of such dramatic symptom reversal from CUR as I did from BCLI. The biggest strength of CUR seems to be the length in which it has stabilized the illness.
Any talk of CUR entering a partnership with BCLI. I think together this could be very big. CUR seems to have had better results in stabilizing the condition, 800 day (per poster on this baord). BCLI seems to be having more success in reversing the symptoms, dramatic results (you can google youtube). But from what I've seen after 6 months there is some regression.
What if treatment began with BCLI to reverse a lot of the symptoms and once stabilized, CUR gets involved to maintain and prolong the treatment. I think synergy between the two could be extremely beneficial.
BCLI, today announced partnership with the Mayo Clinic for this new treatment. I would like to hear of CUR being involved.
The tech. is real. This is big news, makes me extremely comfortable to hold my shares this year knowing they were vetted by the Mayo clinic for testing.